Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;35(1):66-69.
doi: 10.1589/jpts.35.66. Epub 2023 Jan 1.

Effect of intramuscular lidocaine injection with physical therapy on camptocormia in patients with Parkinson's disease who had previously had deep brain stimulation

Affiliations

Effect of intramuscular lidocaine injection with physical therapy on camptocormia in patients with Parkinson's disease who had previously had deep brain stimulation

Toshitaka Sakai et al. J Phys Ther Sci. 2023 Jan.

Abstract

[Purpose] We aimed to evaluate the effects of an intervention consisting of intramuscular lidocaine injection in combination with physical therapy on the standing posture, balance ability, and walking ability in patients with Parkinson's disease who had camptocormia after deep brain stimulation. [Participants and Methods] The participants were nine patients with Parkinson's disease who had previously undergone deep brain stimulation. The intervention comprised a lidocaine injection into the abdominal external oblique muscles for five days in combination with physical therapy, including body weight-supported treadmill training for two weeks. Before and after the intervention, the total and upper camptocormia angles were used to assess the standing posture; the Berg balance scale was used to assess the balancing ability; and maximum walking speed and stride length were used to assess the walking ability. [Results] The total and upper camptocormia angles, and Berg balance scale improved significantly more after the intervention than before. Before and after the intervention, there was no significant difference in maximum walking speed, but the stride length was significantly greater after the intervention than before. [Conclusion] The intervention was effective in alleviating camptocormia and improving the balance and walking abilities of patients with Parkinson's disease with camptocormia after deep brain stimulation.

Keywords: Intramuscular lidocaine injection; Parkinson’s disease; Physical therapy.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest related to this study to disclose.

Figures

Fig. 1.
Fig. 1.
How to measure standing posture. A: total camptocormia angle (TCCangle), B: upper camptocormia angle (UCCangle). TCCangle was defined as the angle on a sagittal image between the line from the L5 spinous process to the C7 spinous process and the line from the L5 spinous process to the lateral malleolus while standing. UCCangle was defined as the angle between the line from the C7 spinous process to the inflection point and the line from the L5 spinous process to the inflection point.

References

    1. Srivanitchapoom P, Hallett M: Camptocormia in Parkinson’s disease: definition, epidemiology, pathogenesis and treatment modalities. J Neurol Neurosurg Psychiatry, 2016, 87: 75–85. - PMC - PubMed
    1. Weaver FM, Follett KA, Stern M, et al. CSP 468 Study Group: Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology, 2012, 79: 55–65. - PMC - PubMed
    1. Bratsos S, Karponis D, Saleh SN: Efficacy and safety of deep brain stimulation in the treatment of Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials. Cureus, 2018, 10: e3474. - PMC - PubMed
    1. Chan AK, Chan AY, Lau D, et al. : Surgical management of camptocormia in Parkinson’s disease: systematic review and meta-analysis. J Neurosurg, 2018, 131: 368–375. - PubMed
    1. Zhou H, Wang L, Zhang C, et al. : Acute effects of subthalmic deep brain stimulation on motor outcomes in Parkinson’s disease; 13 year follow up. Front Neurol, 2019, 10: 689. - PMC - PubMed